Jennifer VanOudenhove

This study identifies MGMT silencing as a therapeutic target in AML and shows that combining O6-fluoroethylating agents with ATR inhibitors improves treatment outcomes.

The paper introduces Cell Marker Accordion, a tool for accurate and interpretable single-cell and spatial omics annotation across health and disease contexts.

The paper identifies novel disease candidate genes in craniofacial development using transcriptomics data and coexpression networks.

The paper creates an epigenomic atlas of early human craniofacial development, identifies novel enhancers, and links them to HOXA genes involved in craniofacial abnormalities.